Royal Capital Wealth Management LLC Buys Shares of 5,296 CME Group Inc. $CME

Royal Capital Wealth Management LLC purchased a new stake in shares of CME Group Inc. (NASDAQ:CME) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 5,296 shares of the financial services provider’s stock, valued at approximately $1,169,000. CME Group accounts for approximately 0.7% of Royal Capital Wealth Management LLC’s portfolio, making the stock its 27th biggest holding.

Other institutional investors have also modified their holdings of the company. Empowered Funds LLC grew its position in CME Group by 11.5% in the 1st quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock worth $2,660,000 after purchasing an additional 1,037 shares during the last quarter. Marshall Wace LLP boosted its position in shares of CME Group by 103.1% during the second quarter. Marshall Wace LLP now owns 3,692 shares of the financial services provider’s stock worth $1,018,000 after buying an additional 121,707 shares during the period. Federated Hermes Inc. boosted its position in shares of CME Group by 1,325.2% during the second quarter. Federated Hermes Inc. now owns 23,572 shares of the financial services provider’s stock worth $6,497,000 after buying an additional 21,918 shares during the period. Nebula Research & Development LLC bought a new position in CME Group in the 2nd quarter worth approximately $992,000. Finally, The Manufacturers Life Insurance Company grew its holdings in CME Group by 2.6% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 287,876 shares of the financial services provider’s stock worth $79,344,000 after buying an additional 7,397 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Price Performance

NASDAQ CME opened at $279.17 on Tuesday. CME Group Inc. has a 12 month low of $218.31 and a 12 month high of $329.16. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a market capitalization of $100.38 billion, a PE ratio of 23.68, a P/E/G ratio of 3.27 and a beta of 0.23. The company’s 50 day simple moving average is $251.43 and its 200 day simple moving average is $279.47.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping the consensus estimate of $2.91 by $0.08. The firm had revenue of $1.71 billion for the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The firm’s quarterly revenue was up .8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.96 earnings per share. As a group, equities research analysts forecast that CME Group Inc. will post 12.27 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be paid a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group’s payout ratio is currently 44.11%.

Insider Activity at CME Group

In other news, Director William R. Shepard acquired 325 shares of the business’s stock in a transaction dated Thursday, June 25th. The stock was acquired at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the acquisition, the director directly owned 260,442 shares in the company, valued at $60,050,111.94. This represents a 0.12% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 0.30% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently commented on CME. Bank of America raised their target price on CME Group from $226.00 to $230.00 and gave the company an “underperform” rating in a research report on Thursday, July 23rd. UBS Group decreased their price target on CME Group from $310.00 to $260.00 and set a “buy” rating for the company in a research note on Monday, July 6th. Raymond James Financial reissued an “outperform” rating and issued a $320.00 price target on shares of CME Group in a research note on Thursday, July 2nd. Deutsche Bank Aktiengesellschaft lowered CME Group from a “buy” rating to a “hold” rating and lowered their price target for the company from $286.00 to $270.00 in a report on Wednesday, August 19th. Finally, TD Cowen reduced their price objective on shares of CME Group from $323.00 to $273.00 and set a “buy” rating for the company in a report on Monday, June 22nd. Nine research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $288.56.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.